Skip to content

Drug interactions

Avapritinib + Vinorelbine

Severity: Minor

Avapritinib and Vinorelbine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vinorelbine is not an established CYP3A4 inhibitor, so a clinically meaningful change in avapritinib exposure is unlikely. Both drugs can cause cytopenias, which may be additive.

What this interaction means in plain words

Avapritinib and Vinorelbine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Avapritinib belongs to Oncology; Vinorelbine belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 competition; no established inhibitory effect, with potential additive myelosuppression.

What to do

No dose change is routinely needed; monitor blood counts during combined therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Avapritinib and Vinorelbine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Avapritinib with Vinorelbine?

MediHelp rates the interaction as minor. Avapritinib and Vinorelbine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Vinorelbine is not an established CYP3A4 inhibitor, so a clinically meaningful change in avapritinib exposure is unlikely. Both drugs can cause cytopenias, which may be additive.

How serious is the interaction between Avapritinib and Vinorelbine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is routinely needed; monitor blood counts during combined therapy.

What other medicines interact with Vinorelbine?

MediHelp also lists interactions of Vinorelbine with, for example, Adenovirus types 4 and 7 live, Apalutamide, Belatacept. The full list is on the Vinorelbine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in